Krystal Biotech, Inc. Shares Outstanding 2016–2025
Krystal Biotech, Inc. (KRYS) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 29.2M | +1.4% |
| FY 2024 | 28.8M | +2.0% |
| FY 2023 | 28.2M | +9.6% |
| FY 2022 | 25.8M | +2.2% |
| FY 2021 | 25.2M | +27.9% |
| FY 2020 | 19.7M | +13.6% |
| FY 2019 | 17.4M | +20.3% |
| FY 2018 | 14.4M | +40.0% |
| FY 2017 | 10.3M | — |
| FY 2016 | 0.0M | — |
Source: Krystal Biotech, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Krystal Biotech, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeKrystal Biotech, Inc. — frequently asked questions
What is Krystal Biotech, Inc.'s shares outstanding?
Krystal Biotech, Inc. (KRYS) reported shares outstanding of 29.2M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Krystal Biotech, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.